Retraction notice to “Corrigendum to ‘Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer’ [International Journal of Biological Macromolecules 248 (2023) 125782]” (International Journal of Biological Macromolecules (2023) 248, (S0141813023026776), (10.1016/j.ijbiomac.2023.125782))

Kianpour M.Huang C.W.Vejvisithsakul P.P.Wang J.Y.Li C.F.Shiao M.S.Pan C.T.Shiue Y.L.Mahidol University2025-01-232025-01-232025-03-01International Journal of Biological Macromolecules Vol.293 (2025)01418130https://repository.li.mahidol.ac.th/handle/20.500.14594/102760This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/locate/withdrawalpolicy). This corrigendum has been retracted at the request of the corresponding authors and the Editor-in-Chief. This corrigendum is being retracted because the article that it corrected has been retracted.Biochemistry, Genetics and Molecular BiologyRetraction notice to “Corrigendum to ‘Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer’ [International Journal of Biological Macromolecules 248 (2023) 125782]” (International Journal of Biological Macromolecules (2023) 248, (S0141813023026776), (10.1016/j.ijbiomac.2023.125782))ErratumSCOPUS10.1016/j.ijbiomac.2024.1389132-s2.0-8521399356718790003